Publicação

Bridging the funding GAP: navigating venture capital for female-specific diseases-insights from femthera

Ver documento

Detalhes bibliográficos
Resumo:This work project analyzes funding challenges that early-stage women’s health therapeutic companies face. It is built on the case of FemThera and was developed in collaboration with the company. It has a specific focus on attracting venture capital investment. The work project draws on a literature review, stakeholder and patient interviews and a venture capital landscape analysis. The outcomes show that structural biases and misconceptions about market size shape investor decisions - despite a proven market need. The findings suggest that meeting key venture capital criteria and targeting investors that align well with the venture can strengthen FemThera’s fundraising position.
Autores principais:Kirchschlager, Laura
Assunto:Women’s health endometriosis Venture capital Early-stage biotech Funding GAP
Ano:2026
País:Portugal
Tipo de documento:dissertação de mestrado
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
Descrição
Resumo:This work project analyzes funding challenges that early-stage women’s health therapeutic companies face. It is built on the case of FemThera and was developed in collaboration with the company. It has a specific focus on attracting venture capital investment. The work project draws on a literature review, stakeholder and patient interviews and a venture capital landscape analysis. The outcomes show that structural biases and misconceptions about market size shape investor decisions - despite a proven market need. The findings suggest that meeting key venture capital criteria and targeting investors that align well with the venture can strengthen FemThera’s fundraising position.